Last updated: August 16, 2021
Sponsor: Nanfang Hospital of Southern Medical University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Vascular Diseases
Stress
Williams Syndrome
Treatment
N/AClinical Study ID
NCT03713606
Pan-CHESS1802
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- age 18-75 years;
- confirmed cirrhosis based on histologic examination of liver or combined physical,laboratory, and radiologic findings, including a nodular surface, a coarse texture,and an enlarged caudate lobe of the liver.
Exclusion
Exclusion Criteria:
- prior drug therapy (e.g. β-blocker, vasopressin) within two weeks
- prior surgeries (e.g. TIPS, partial splenic embolization/ devascularization,splenectomy, liver transplantation)
- non-sinusoidal portal hypertension & HCC inability to adhere to study procedures
- pregnancy or unknown pregnancy status
- no informed consent
Study Design
Total Participants: 75
Study Start date:
September 30, 2018
Estimated Completion Date:
June 01, 2022
Study Description
Connect with a study center
302 Hospital of PLA
Beijing,
ChinaActive - Recruiting
Beijing Friendship Hospital
Beijing,
ChinaActive - Recruiting
Beijing Shijitan Hospital
Beijing,
ChinaActive - Recruiting
Beijing YouAn Hospital
Beijing,
ChinaActive - Recruiting
Shandong Provincial Hospital
Jinan,
ChinaActive - Recruiting
Xingtai People's Hospital
Xingtai,
ChinaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.